News
Summit Therapeutics plc : Total voting rights
Oxford, UK, and Cambridge, MA, US, 1 May 2018- Summit Therapeutics plc announces in accordance with Disclosure and Transparency Rule 5.6. 1 that as of 30 April 2018, the Company's issued share capital consisted of 81,989,004 ordinary shares of one penny nominal value. The Company does not hold any ordinary shares in treasury. Therefore, the total number of voting...
Oxford, UK, and Cambridge, MA, US, 1 May 2018- Summit Therapeutics plc announces in accordance with Disclosure and Transparency Rule 5.6. 1 that as of 30 April 2018, the Company's issued share capital consisted of 81,989,004 ordinary shares of one penny nominal value. The Company does not hold any ordinary shares in treasury. Therefore, the total number of voting...